- Credit Type: CPE
- Credit Amount: 1.00
- Cost: $5.00
- Release: Feb 9, 2015
- Expires: Oct 23, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Kentucky Hospital Association Endowed Professor, Clinical Pharmacy and Science
University of Kentucky Colleges of Pharmacy and Medicine
Needs StatementThe difference between current practice and optimal practice relevant to the educational need is to make pharmacists and techs feel more confident about their role in adherence and management of pediatric asthma. A better review of device, drug delivery and treatment guidelines for pediatric asthma are needed.
ObjectivesUpon Completion of this activity Pharmacist will be able to:
1. Describe practical solutions to aerosol drug delivery to children with asthma
2. Identify barriers to medication adherence in children with asthma
3. Describe the role of new medications and devices for the management of pediatric asthma
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-15-015-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.
Faculty DisclosureRobert Kuhn, PharmD (Speaker) has no relevant financial relationships with commercial interests.
Robert Kuhn does not intend to discuss the off-label use of a product.
No planners have any relevant financial relationships to disclose.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.